6-K - Organigram Global Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Organigram Global Inc. announced the mailing of its management information circular for the March 30, 2026 annual and special meeting, where shareholders will vote on approving the acquisition of remaining shares of Sanity Group GmbH for an upfront €113.4 million and potential earnout up to €113.8 million, alongside a C$65.2 million private placement from BAT. The board unanimously recommends voting in favor, deeming the transaction fair and in the company's best interests.

Key Takeaways

1Mailed management information circular for March 30, 2026 meeting

2Shareholder vote on acquisition of Sanity Group GmbH shares not already owned

3Upfront consideration: €80.0 million cash + €33.4 million in shares at $3.00 per share (71% TSX premium)

4Earnout up to €113.8 million based on 12-month post-closing performance

5BAT private placement: 23,924,430 shares at $3.00 for C$65.2 million gross proceeds

6Closing conditions include TSX approval, German FDI clearance, and shareholder approval

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Transaction Details

Acquisition / Disposition

Target: all issued and outstanding shares of Sanity Group GmbH not already owned by the Company
Consideration: €113.4 million upfront (€80.0 million cash, €33.4 million in Common Shares or Class A Preferred Shares at $3.00 per Share); earnout up to €113.8 million (€20.0 million cash, €93.8 million in Shares)
Structure: Share purchase agreement dated February 18, 2026

•Meeting on March 30, 2026
•TSX regulatory approval
•NASDAQ notification
•German Ministry of Economics and Energy FDI clearance
•Shareholder approval of Transaction Resolution

Exhibits (2)

6-K

99.1

EX-99.1